| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |